Pose-Vilarnovo B, Perdomo-López I, Echezarreta-López M, Schroth-Pardo P, Estrada E, Torres-Labandeira J J
Departamento de Farmacia e Tecnoloxía Farmacéutica, Fac. de Farmacia, Univ. de Santiago de Compostela, Campus Sur, E-15782 Santiago de Compostela, Spain.
Eur J Pharm Sci. 2001 Jun;13(3):325-31. doi: 10.1016/s0928-0987(01)00131-2.
The aim of this study was to increase the solubility of sulfamethizole in water by complexing it with beta-cyclodextrin (BCD) and hydroxypropyl-beta-cyclodextrin (HPBCD). The interaction of sulfamethizole with the cyclodextrins was evaluated by the solubility, 1H NMR spectrometry and molecular modelling. The stability constants calculated from the phase solubility method increase in order HPBCD<BCD. From the NMR studies could be concluded that the sulfamethizole:cyclodextrin mole ratio was 1:1 (mol/mol) in the BCD complex and 2:3 (mol/mol) in the HPBCD complex. In both cases the sulfamethizole moiety included in the cyclodextrin was the thiadiazole group. MM2 calculations, either in vacuum or in the presence of a solvent, support this structure. Solid inclusion complexes of sulfamethizole with BCD and HPBCD were obtained by freeze drying 1:1 (mol/mol) solutions in aqueous ammonium hydroxide. Host-guest interactions were studied in the solid state by powder X-ray diffractometry and differential scanning calorimetry. The dissolution rates of sulfamethizole increased by the complexation with BCD or HPBCD.
本研究的目的是通过将磺胺甲噻二唑与β-环糊精(BCD)和羟丙基-β-环糊精(HPBCD)络合来提高其在水中的溶解度。通过溶解度、1H核磁共振光谱法和分子模拟评估了磺胺甲噻二唑与环糊精的相互作用。由相溶解度法计算得到的稳定常数按HPBCD<BCD的顺序增加。从核磁共振研究可以得出结论,在BCD络合物中磺胺甲噻二唑与环糊精的摩尔比为1:1(摩尔/摩尔),在HPBCD络合物中为2:3(摩尔/摩尔)。在这两种情况下,环糊精中包含的磺胺甲噻二唑部分都是噻二唑基团。无论是在真空中还是在有溶剂存在的情况下进行的MM2计算都支持这种结构。通过冷冻干燥氢氧化铵水溶液中的1:1(摩尔/摩尔)溶液,得到了磺胺甲噻二唑与BCD和HPBCD的固体包合物。通过粉末X射线衍射法和差示扫描量热法在固态下研究了主客体相互作用。与BCD或HPBCD络合后,磺胺甲噻二唑的溶解速率增加。